Literature DB >> 7448681

Increased requirement for thyroid hormone after a jejunoileal bypass operation.

D J Topliss, J A Wright, R Volpé.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7448681      PMCID: PMC1704859     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  WHOLE-BODY COUNTING OF I-131-LABELED THYROXINE.

Authors:  T H ODDIE; D A FISHER; C ROGERS
Journal:  J Clin Endocrinol Metab       Date:  1964-07       Impact factor: 5.958

2.  Thyroxine metabolism in untreated and treated pancreatic steatorrhea.

Authors:  J M HISS; J T DOWLING
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  Malabsorption of thyroid hormones after jejunoileal bypass for obesity.

Authors:  F Azizi; R Belur; J Albano
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

4.  Effect of high- and low-bulk diets on the thyroxine turnover rate in rats with acute and chronic exposure to different temperatures.

Authors:  O Héroux; V M Petrovic
Journal:  Can J Physiol Pharmacol       Date:  1969-12       Impact factor: 2.273

5.  Absorption of thyroxine from the intestine of rats.

Authors:  S J Chung; L Van Middlesworth
Journal:  Am J Physiol       Date:  1967-01

6.  Absorption of oral thyroxine in man.

Authors:  M T Hays
Journal:  J Clin Endocrinol Metab       Date:  1968-06       Impact factor: 5.958

7.  Absorption of triiodothyronine in man.

Authors:  M T Hays
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

8.  Intestinal bypass surgery for morbid obesity. Long-term results.

Authors:  L T DeWind; J H Payne
Journal:  JAMA       Date:  1976-11-15       Impact factor: 56.272

  8 in total
  7 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Levothyroxine Dosing Following Bariatric Surgery.

Authors:  Silpa Gadiraju; Clare J Lee; David S Cooper
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

4.  The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients.

Authors:  Jorge Pedro; Filipe Cunha; Pedro Souteiro; João Sérgio Neves; Vanessa Guerreiro; Daniela Magalhães; Rita Bettencourt-Silva; Sofia Castro Oliveira; Maria Manuel Costa; Joana Queirós; Paula Freitas; Ana Varela; Davide Carvalho
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

Review 5.  Caveats in treating thyroid disease: practical implications.

Authors:  G I Varughese; A A Tahrani; J Davis; R N Clayton; F W F Hanna
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

Review 6.  Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery.

Authors:  María Cordido; Paula Juiz-Valiña; Paula Urones; Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

7.  Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review.

Authors:  Wallace Bok-Thoe Hong; Wee Kiat Tan; Lawrence Siu-Chun Law; David Eng-Hui Ong; Elaine Ah-Gi Lo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-07-01       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.